2016
DOI: 10.1021/acsmedchemlett.6b00009
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability

Abstract: Cannabidiol is the nonpsychoactive natural component of C. sativa that has been shown to be neuroprotective in multiple animal models. Our interest is to advance a therapeutic candidate for the orphan indication hepatic encephalopathy (HE). HE is a serious neurological disorder that occurs in patients with cirrhosis or liver failure. Although cannabidiol is effective in models of HE, it has limitations in terms of safety and oral bioavailability. Herein, we describe a series of side chain modified resorcinols … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
42
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 43 publications
(47 citation statements)
references
References 21 publications
2
42
0
2
Order By: Relevance
“…Other studies have used dissociated hippocampal cultures derived from embryonic day 18 rats to measure toxicity and neuroprotective responses to CBD. These studies indicate that the EC 50 of CBD is within the 1–4 μ m range while causing neurotoxicity at 33 μ m ( 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…Other studies have used dissociated hippocampal cultures derived from embryonic day 18 rats to measure toxicity and neuroprotective responses to CBD. These studies indicate that the EC 50 of CBD is within the 1–4 μ m range while causing neurotoxicity at 33 μ m ( 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…The neuroprotective properties of CBD against oligomycin, an inhibitor of ATP synthetase, 10 and ammonium acetate and ethanol in the hippocampal neuron culture also have been reported. 13 Oxidative stress is thought to cause pathological conditions in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotropic lateral sclerosis. 14,15 The cytoprotective effect of CBD against hydrogen peroxide (H 2 O 2 ), a crucial metabolic molecule in the oxidative stress, 16 was reported for cerebellar granule cells 17 and oligodendrocyte progenitor cells, 18 but there have been no reports on its effect against H 2 O 2 in the neurons that are more relevant to the brain function, such as hippocampal neurons.…”
Section: Introductionmentioning
confidence: 99%
“…Synthetic C4′ analogs of (−)‐CBD have been designed and executed for achieving better potency, safety, and permeability, as a neuroprotective drug, than (−)‐CBD . For example, the compound 43 , having the N ‐acetyl azetidine moiety, showed better pharmacological performance: the EC 50 value of 2,000 n m (EC 50 of (−)‐CBD: 40 m m ) and 400‐fold‐enhanced in vitro safety for hippocampal neurons. The synthesis of the compound 43 was started with the compound 50 (Scheme ).…”
Section: C4′ Analogsmentioning
confidence: 99%